PTC Therapeutics, Inc. Shares Outstanding (Cover Page)
PTC Therapeutics, Inc. (PTCT) had Shares Outstanding (Cover Page) of 83.46 million shares as of 2026-07-29, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-29: Entity Common Stock, Shares Outstanding 83.46M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 8.29M shares.
- 2026-02-18: Entity Common Stock, Shares Outstanding 82.77M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 80.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-29 | 83.46M shares 10-Q · filed 2026-07-30 |
| 2026-05-05 | 8.29M shares 10-Q · filed 2026-05-07 |
| 2026-02-18 | 82.77M shares 10-K · filed 2026-02-19 |
| 2025-11-03 | 80.29M shares 10-Q · filed 2025-11-04 |
| 2025-08-05 | 79.44M shares 10-Q · filed 2025-08-07 |
| 2025-05-04 | 79.26M shares 10-Q · filed 2025-05-06 |
| 2025-02-25 | 78.87M shares 10-K · filed 2025-02-27 |
| 2024-11-05 | 77.13M shares 10-Q · filed 2024-11-07 |
| 2024-08-06 | 76.92M shares 10-Q · filed 2024-08-08 |
| 2024-04-23 | 76.70M shares 10-Q · filed 2024-04-25 |
| 2024-02-27 | 76.61M shares 10-K · filed 2024-02-29 |
| 2023-10-24 | 75.46M shares 10-Q · filed 2023-10-26 |
| 2023-08-01 | 75.34M shares 10-Q · filed 2023-08-03 |
| 2023-04-25 | 74.19M shares 10-Q · filed 2023-04-27 |
| 2023-02-16 | 73.82M shares 10-K/A · filed 2023-03-08 |
| 2022-10-25 | 71.88M shares 10-Q · filed 2022-10-27 |
| 2022-08-02 | 71.54M shares 10-Q · filed 2022-08-04 |
| 2022-05-02 | 71.34M shares 10-Q · filed 2022-05-03 |
| 2022-02-18 | 71.36M shares 10-K · filed 2022-02-22 |
| 2021-10-27 | 70.70M shares 10-Q · filed 2021-10-28 |
| 2021-07-28 | 70.60M shares 10-Q · filed 2021-07-29 |
| 2021-05-03 | 70.46M shares 10-Q · filed 2021-05-04 |
| 2021-02-23 | 70.32M shares 10-K · filed 2021-02-25 |
| 2020-10-27 | 68.24M shares 10-Q · filed 2020-10-29 |
| 2020-08-03 | 67.70M shares 10-Q · filed 2020-08-05 |
| 2020-04-28 | 62.88M shares 10-Q · filed 2020-04-30 |
| 2020-02-27 | 62.63M shares 10-K · filed 2020-03-02 |
| 2019-10-25 | 61.63M shares 10-Q · filed 2019-10-30 |
| 2019-08-05 | 58.95M shares 10-Q · filed 2019-08-06 |
| 2019-04-29 | 58.43M shares 10-Q · filed 2019-05-02 |
| 2019-02-25 | 58.40M shares 10-K · filed 2019-03-01 |
| 2018-11-01 | 50.45M shares 10-Q · filed 2018-11-05 |
| 2018-08-03 | 46.71M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 46.45M shares 10-Q · filed 2018-05-09 |
| 2018-02-28 | 41.80M shares 10-K · filed 2018-03-06 |
| 2017-10-31 | 41.49M shares 10-Q · filed 2017-11-02 |
| 2017-08-04 | 41.39M shares 10-Q · filed 2017-08-09 |
| 2017-05-05 | 41.24M shares 10-Q · filed 2017-05-08 |
| 2017-02-24 | 34.56M shares 10-K · filed 2017-03-16 |
| 2016-11-01 | 34.32M shares 10-Q · filed 2016-11-03 |
| 2016-08-01 | 34.25M shares 10-Q · filed 2016-08-04 |
| 2016-05-02 | 34.27M shares 10-Q · filed 2016-05-05 |
| 2016-02-24 | 34.27M shares 10-K · filed 2016-02-29 |
| 2015-11-04 | 34.27M shares 10-Q · filed 2015-11-09 |
| 2015-07-29 | 34.27M shares 10-Q · filed 2015-07-31 |
| 2015-04-30 | 33.85M shares 10-Q · filed 2015-05-05 |
| 2015-02-24 | 33.69M shares 10-K · filed 2015-03-02 |
| 2014-11-05 | 33.60M shares 10-Q · filed 2014-11-06 |
| 2014-08-04 | 30.07M shares 10-Q · filed 2014-08-07 |
| 2014-05-05 | 30.07M shares 10-Q · filed 2014-05-06 |
| 2014-03-04 | 30.08M shares 10-K · filed 2014-03-06 |
| 2013-11-13 | 24.92M shares 10-Q · filed 2013-11-14 |
| 2013-08-12 | 24.92M shares 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |